Sanofi Pasteur, a Sanofi Company
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Sanofi Pasteur, a Sanofi Company sits in the top decile of US sponsors by registered trial count (#190 of 15,742 sponsors by registered trial count).
Sanofi Pasteur, a Sanofi Company: 153 sponsored US clinical trials, 3 recruiting.
Sanofi Pasteur, a Sanofi Company sponsors 153 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 132 completed. 71 of these trials are in Phase 3-4 (later-stage) and 67 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Influenza, with 16 trials.
Top-decile sponsor footprint
Sanofi Pasteur, a Sanofi Company ranks in the top decile of sponsors by registered trial count (#190 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
132 of 144 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
153 total, page 4 of 4
Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine
NCT00772070
Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®
NCT00850603
Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
NCT00053508
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 31 |
| Phase 2 | 36 |
| Phase 3 | 33 |
| Phase 4 | 38 |
Therapeutic Areas
What is open in the Sanofi Pasteur, a Sanofi Company pipeline
3 recruiting of 153 indexed (2% open); 132 completed (86%).
Phase mix: 71 late (III/IV) vs 67 early (I/II) (balanced across stages).
Top condition: Influenza (16 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Sanofi Pasteur, a Sanofi Company: open-pipeline peers nationwide
Peers matched on 153 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Sanofi Pasteur, a Sanofi Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 153 trials (± recruiting share)
- Gynecologic Oncology Group · 154 trials · 1% recruiting
- University of South Carolina · 157 trials · 19% recruiting
- Galderma R&D · 158 trials · 4% recruiting
- Pfizer's Upjohn has merged with Mylan to form Viatris · 158 trials · 0% recruiting
Sponsors near 2% open enrollment (± trial volume)
- PTC Therapeutics · 2% recruiting · 52 trials
- Spectrum Pharmaceuticals · 2% recruiting · 52 trials
- Carelon Research · 2% recruiting · 50 trials
- Société des Produits Nestlé (SPN) · 2% recruiting · 53 trials
Related
What to do with this Sanofi Pasteur, a Sanofi Company page
153 registered trials is a research-attention snapshot, not an endorsement of Sanofi Pasteur, a Sanofi Company or any single study.
- 3 of Sanofi Pasteur, a Sanofi Company's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Influenza is the condition Sanofi Pasteur, a Sanofi Company studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Influenza trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Sanofi Pasteur, a Sanofi Company pipeline card: 153 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.